Allarity Therapeutics, Inc. (ALLR) vs Dyadic International, Inc. (DYAI)

A side-by-side comparison of Allarity Therapeutics, Inc. and Dyadic International, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ALLR vs DYAI

growth of $100 · dividends reinvested · last 5y
ALLR -100.0% (-95.9%/yr)DYAI -88.5% (-35.1%/yr)DYAI compounded faster over this window
Log scale — wide-divergence pair
0000001101001kStart $10020222023202420252026$0$11
ALLR DYAI

ALLR vs DYAI: by the numbers

  • •DYAI is the larger company ($16M vs $16M market cap).
  • •Both run net losses; DYAI's is the smaller (-219.50% vs -3575.07% net margin).

Metrics side by side

Valuation

MetricALLRDYAI
P/S ratio45.544.72
P/B ratio4.44N/A

Profitability

MetricALLRDYAI
Gross margin107.54%-88.25%
Operating margin-3939.06%-579.88%
Net margin-3575.07%-219.50%
ROE-348.81%N/A
ROIC-41.81%-279.48%

Growth (annualized)

MetricALLRDYAI
Revenue CAGR (5Y)N/A-5.11%
Total return CAGR (5Y)N/A-38.53%

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.